SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-009624
Filing Date
2023-05-12
Accepted
2023-05-12 17:15:37
Documents
67
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q azyo-20230331x10q.htm   iXBRL 10-Q 1333588
2 EX-10.4 azyo-20230331xex10d4.htm EX-10.4 49118
3 EX-31.1 azyo-20230331xex31d1.htm EX-31.1 15113
4 EX-31.2 azyo-20230331xex31d2.htm EX-31.2 15102
5 EX-32.1 azyo-20230331xex32d1.htm EX-32.1 6765
6 EX-32.2 azyo-20230331xex32d2.htm EX-32.2 6719
  Complete submission text file 0001558370-23-009624.txt   5918816

Data Files

Seq Description Document Type Size
7 EX-101.SCH azyo-20230331.xsd EX-101.SCH 48123
8 EX-101.CAL azyo-20230331_cal.xml EX-101.CAL 39101
9 EX-101.DEF azyo-20230331_def.xml EX-101.DEF 226328
10 EX-101.LAB azyo-20230331_lab.xml EX-101.LAB 427966
11 EX-101.PRE azyo-20230331_pre.xml EX-101.PRE 337812
61 EXTRACTED XBRL INSTANCE DOCUMENT azyo-20230331x10q_htm.xml XML 820009
Mailing Address 12510 PROSPERITY DRIVE SUITE 370 SILVER SPRING MD 20904
Business Address 12510 PROSPERITY DRIVE SUITE 370 SILVER SPRING MD 20904 240-247-1143
AZIYO BIOLOGICS, INC. (Filer) CIK: 0001708527 (see all company filings)

IRS No.: 474790334 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39577 | Film No.: 23917015
SIC: 2836 Biological Products, (No Diagnostic Substances)